Therapeutic options in the treatment of benign prostatic hyperplasia

被引：0

作者：

Sandhu, Jaspreet S. ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Surg, Div Urol, New York, NY 10065 USA

来源：

PATIENT PREFERENCE AND ADHERENCE | 2009年 / 3卷

关键词：

benign prostatic hyperplasia; prostatectomy; TURP; URINARY-TRACT SYMPTOMS; TOLTERODINE EXTENDED-RELEASE; HOLMIUM LASER ENUCLEATION; TRANSURETHRAL RESECTION; PHOTOSELECTIVE VAPORIZATION; OVERACTIVE BLADDER; BOTULINUM TOXIN; NATURAL-HISTORY; FINASTERIDE; MEN;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Current theraputic options for the treatment of symptomatic benign prostatic hyperplasia (BPH) are reviewed. Therapeutic options for mild lower urinary tract symptoms (LUTS), as defined by the American Urological Association, are generally treated medically. Moderate to severe LUTS can be treated medically or with surgical therapy. Current medical and surgical treatments for LUTS secondary to BPH are reviewed and evolving treatments are explored.

引用

页码：213 / 223

页数：11

共 85 条

[1]

[Anonymous], AHCPR PUBLICATION

[2] Aua guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations [J].

JOURNAL OF UROLOGY, 2003, 170 (02) :530-547

[3] Study design of the Medical Therapy of Prostatic Symptoms (MTOPS) trial [J].

Bautista, OM ;

Kusek, JW ;

Nyberg, LM ;

McConnell, JD ;

Bain, RP ;

Miller, G ;

Crawford, ED ;

Kaplan, SA ;

Sihelnik, SA ;

Brawer, MK ;

Lepor, H .

CONTROLLED CLINICAL TRIALS, 2003, 24 (02) :224-243

[4]

BEISLAND HO, 1992, EUR UROL, V22, P271

[5] THE DEVELOPMENT OF HUMAN BENIGN PROSTATIC HYPERPLASIA WITH AGE [J].

BERRY, SJ ;

COFFEY, DS ;

WALSH, PC ;

EWING, LL .

JOURNAL OF UROLOGY, 1984, 132 (03) :474-479

[6] Evaluation and management of benign prostatic hyperplasia: Proceedings of a Thought Leader Conference held March 31, 2001 - Introduction [J].

Blute, ML ;

Jacobsen, SJ ;

Kaplan, SA ;

Lowe, FC ;

O'Leary, MP ;

Steers, WD ;

Roehrborn, CG .

UROLOGY, 2001, 58 (6A) :1-4

[7] Electrovaporization of the prostate with the Gyrus device [J].

Botto, H ;

Lebret, T ;

Barré, P ;

Orsoni, JL ;

Hervé, JM ;

Lugagne, PM .

JOURNAL OF ENDOUROLOGY, 2001, 15 (03) :313-316

[8] Systematic review and meta-analysis of Transurethral Needle Ablation in symptomatic benign prostatic hyperplasia [J].

Bouza C. ;

López T. ;

Magro A. ;

Navalpotro L. ;

Amate J.M. .

BMC Urology, 6 (1)

[9] Relief by Botulinum Toxin of Lower Urinary Tract Symptoms Owing to Benign Prostatic Hyperplasia: Early and Long-Term Results [J].

Brisinda, Giuseppe ;

Cadeddu, Federica ;

Vanella, Serafino ;

Mazzeo, Pasquale ;

Maria, Giorgio .

UROLOGY, 2009, 73 (01) :90-94

[10] Effect of finasteride on bother and other health-related quality of life aspects associated with benign prostatic hyperplasia [J].

Bruskewitz, R ;

Girman, CJ ;

Fowler, J ;

Rigby, OF ;

Sullivan, M ;

Bracken, RB ;

Fusilier, HA ;

Kozlowski, D ;

Kantor, SD ;

Johnson, EL ;

Wang, DZ ;

Waldstreicher, J .

UROLOGY, 1999, 54 (04) :670-678

← 1 2 3 4 5 6 7 8 9 →